Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04731714 · ClinicalTrials.gov registry record · NA
Median Nerve Stimulation Pilot
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04731714 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 34 participants.
The verdict
NCT04731714, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Results from the University of Nottingham suggested that rhythmic median nerve stimulation (MNS) improves tic symptoms in Tourette syndrome (TS). The investigators will (1) provide a first replication of their study, (2) test the hypothesized electrophysiological mechanism and rule out a placebo effect as cause for the symptomatic benefit, and (3) gather information on the duration of effect after the end of stimulation and on individual characteristics that predict improvement with simulation. Completion of these Aims will give a clear go/no-go signal for a future clinical trial of chronic MNS delivered by a yet-to-be-developed wristwatch-style device. NOTE: This study is not intended to evaluate a specific device for future use. Rather it is a study to determine the action of pulsed electrical stimulation on tic symptoms and to gain early evidence of effectiveness. This is a non-significant risk device study.
Interventions
- DEVICE Rhythmic median nerve stimulation
- DEVICE Arrhythmic median nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2022-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04731714
The ClinicalTrials.gov registry entry for NCT04731714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rhythmic median nerve stimulation is the first listed.
NCT04731714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04731714 about?
NCT04731714 is a clinical study titled "Median Nerve Stimulation Pilot". Results from the University of Nottingham suggested that rhythmic median nerve stimulation (MNS) improves tic symptoms in Tourette syndrome (TS). The investigators will (1) provide a first replication of their study, (2) test the hypothesized electrophysiological mechanism and rule out a placebo eff...
What is the current status of trial NCT04731714?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-07-15. Estimated completion is 2022-04-27.
What interventions are being tested in trial NCT04731714?
The interventions under investigation include: Rhythmic median nerve stimulation (DEVICE), Arrhythmic median nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT04731714?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.